4.7 Article

RNA Trans-Splicing Modulation via Antisense Molecule Interference

Journal

Publisher

MDPI
DOI: 10.3390/ijms19030762

Keywords

RNA trans-splicing; RNA therapy; fluorescence-based screening system; antisense molecules; epidermolysis bullosa; KRT14

Funding

  1. Austrian Science Fund (FWF) [P 27336-B26]
  2. Paracelsus Medical University, Salzburg, Austria (PMU-FF) [A-15/01/016-KOL]
  3. DEBRA Austria
  4. Austrian Science Fund (FWF) [P27336] Funding Source: Austrian Science Fund (FWF)

Ask authors/readers for more resources

In recent years, RNA trans-splicing has emerged as a suitable RNA editing tool for the specific replacement of mutated gene regions at the pre-mRNA level. Although the technology has been successfully applied for the restoration of protein function in various genetic diseases, a higher trans-splicing efficiency is still desired to facilitate its clinical application. Here, we describe a modified, easily applicable, fluorescence-based screening system for the generation and analysis of antisense molecules specifically capable of improving the RNA reprogramming efficiency of a selected KRT14-specific RNA trans-splicing molecule. Using this screening procedure, we identified several antisense RNAs and short rationally designed oligonucleotides, which are able to increase the trans-splicing efficiency. Thus, we assume that besides the RNA trans-splicing molecule, short antisense molecules can act as splicing modulators, thereby increasing the trans-splicing efficiency to a level that may be sufficient to overcome the effects of certain genetic predispositions, particularly those associated with dominantly inherited diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available